These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16185301)

  • 41. Serotonin: receptors and antagonists--summary of symposium.
    Prichard BN; Smith CC
    Clin Physiol Biochem; 1990; 8 Suppl 3():120-8. PubMed ID: 2132173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system.
    McCall RB; Clement ME
    Pharmacol Rev; 1994 Sep; 46(3):231-43. PubMed ID: 7831380
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pharmacology of 5-hydroxytryptamine receptors].
    Fontaine J
    J Pharm Belg; 1996; 51(3):141-51. PubMed ID: 8778347
    [No Abstract]   [Full Text] [Related]  

  • 44. Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory.
    Meneses A
    Behav Brain Res; 2007 Nov; 184(1):81-90. PubMed ID: 17692935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A neurohormonal role for serotonin in the control of locust oviducts.
    Lange AB
    Arch Insect Biochem Physiol; 2004 Aug; 56(4):179-90. PubMed ID: 15274179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction.
    Lau DH; Thompson CS; Bellringer JF; Thomas PJ; Mumtaz FH; Morgan RJ; Mikhailidis DP
    J Androl; 2006; 27(5):679-85. PubMed ID: 16728720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice.
    Cachard-Chastel M; Lezoualc'h F; Dewachter I; Deloménie C; Croes S; Devijver H; Langlois M; Van Leuven F; Sicsic S; Gardier AM
    Br J Pharmacol; 2007 Apr; 150(7):883-92. PubMed ID: 17325649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [5-HT3-receptor-antagonists in therapy of rheumatic diseases].
    Müller W; Stratz T
    Z Rheumatol; 2003 Feb; 62(1):39-41. PubMed ID: 12624802
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of 5-HT3 and 5-HT4 receptors in the adaptive mechanism of colonic transit following the parasympathetic denervation in rats.
    Tong W; Kamiyama Y; Ridolfi TJ; Zietlow A; Zheng J; Kosinski L; Ludwig K; Takahashi T
    J Surg Res; 2011 Dec; 171(2):510-6. PubMed ID: 20691988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of 5-hydroxytryptamine agonists and antagonists on cholera toxin induced intestinal fluid accumulation in conscious rats.
    Ku P; Lee CH; Smith WL; Jett MF
    Proc West Pharmacol Soc; 1992; 35():221-6. PubMed ID: 1502229
    [No Abstract]   [Full Text] [Related]  

  • 51. [5HT-3 receptors: characteristics and therapeutic implications of a new subtype of 5-hydroxytryptamine receptors].
    Samardzić R; Jovanović-Mićić D; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(3-4):82-5. PubMed ID: 17972816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Physiopathological and therapeutic perspectives on the new serotonin receptors: the type 4 receptor].
    Lefebvre H
    Rev Med Interne; 2000 Aug; 21(8):661-3. PubMed ID: 10989490
    [No Abstract]   [Full Text] [Related]  

  • 53. 5-HT2B receptors do not modulate sensitivity to colonic distension in rats with acute colorectal hypersensitivity.
    Greenwood-Van Meerveld B; Campbell-Dittmeyer K; Johnson AC; Hicks GA
    Neurogastroenterol Motil; 2006 May; 18(5):343-5. PubMed ID: 16629860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of serotonin type 4 receptor expression in human and non-human primate gastrointestinal samples.
    Mader R; Kocher T; Haier J; Wieczorek G; Pfannkuche HJ; Ito M
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):945-50. PubMed ID: 16894306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-HT4 receptor and Alzheimer's disease: the amyloid connection.
    Lezoualc'h F
    Exp Neurol; 2007 Jun; 205(2):325-9. PubMed ID: 17346704
    [No Abstract]   [Full Text] [Related]  

  • 57. A nonneuronal 5-hydroxytryptamine receptor 3 induces chloride secretion in the rat distal colonic mucosa.
    Day J; King B; Haque SM; Kellum JM
    Am J Surg; 2005 Nov; 190(5):736-8. PubMed ID: 16226950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus.
    Crowell MD; Mathis C; Schettler VA; Yunus T; Lacy BE
    Neurogastroenterol Motil; 2005 Oct; 17(5):738-43. PubMed ID: 16185313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-HT receptors and visceral hypersensitivity - 2B or not 2B, that is the question?
    Grundy D
    Neurogastroenterol Motil; 2006 May; 18(5):339-42. PubMed ID: 16629859
    [No Abstract]   [Full Text] [Related]  

  • 60. [History and new developments. The pharmacology of 5-ht3 antagonists].
    Rex A; Bert B; Fink H
    Pharm Unserer Zeit; 2007; 36(5):342-53. PubMed ID: 17722161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.